Sharon Mates, Chairman, President & CEO at Intra-Cellular Therapies, Inc. (ITCI), sold 50,000 shares at $40.00 ($2.0M) on 2021-10-14, disclosed to the SEC on 2021-10-18.
Open-market sale of $2.0M ITCI by Chairman, President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 1,416 | $57K | 2.8% |
| 2 | $40.00 | 40,392 | $1.6M | 80.8% |
| 3 | $40.00 | 8,192 | $328K | 16.4% |
| Total | $40.00 avg | 50,000 | $2.0M | 100% |
| Filing → |
| ITCI | SELL | 2024-08-28 | $14.1M | — | Filing → |
| ITCI | SELL | 2024-08-23 | $18.0M | — | Filing → |
| ITCI | SELL | 2024-03-11 | $8.1M | — | Filing → |